Arovella Therapeutics (E4NA.F) Q1 2025 Earnings

27FebConfirmed
Q1 2024
Q3 2024
Q1 2025
-0
-0
-0
-0

Details

Expected EPS
-0.001189826144
Actual EPS
-0.0008328783008
Surprise EPS
0
Surprise Percent
+30%

Description

Arovella Therapeutics (E4NA.F) has reported earnings of -0.0008328783008 per share for Q1 2025.

0 Comments

Share your thoughts